Integrated Molecular Characterization of Uterine Carcinosarcoma.

PubWeight™: 0.92^‹?›

🔗 View Article (PMID 28292439)

Published in Cancer Cell on March 13, 2017

Authors

Andrew D Cherniack¹, Hui Shen², Vonn Walter³, Chip Stewart¹, Bradley A Murray¹, Reanne Bowlby⁴, Xin Hu⁵, Shiyun Ling⁵, Robert A Soslow⁶, Russell R Broaddus⁵, Rosemary E Zuna⁷, Gordon Robertson⁴, Peter W Laird², Raju Kucherlapati⁸, Gordon B Mills⁵, Cancer Genome Atlas Research Network, John N Weinstein⁵, Jiashan Zhang⁹, Rehan Akbani¹⁰, Douglas A Levine¹¹

Author Affiliations

1: The Eli and Edythe L. Broad Institute of Massachusetts Institute of Technology and Harvard University, Cambridge, MA 02142, USA.
2: Van Andel Research Institute, Center for Epigenetics, Grand Rapids, MI 49503, USA.
3: Lineberger Comprehensive Cancer Center, University of North Carolina at Chapel Hill, Chapel Hill, NC 27599, USA.
4: Canada's Michael Smith Genome Sciences Center, BC Cancer Agency, Vancouver, BC V5Z 4S6, Canada.
5: The University of Texas MD Anderson Cancer Center, Houston, TX 77030, USA.
6: Memorial Sloan Kettering Cancer Center, New York, NY 10065, USA.
7: Stephenson Cancer Center, University of Oklahoma Health Sciences Center, Oklahoma City, OK 73104, USA.
8: Harvard Medical School, Boston, MA 02115, USA.
9: National Cancer Institute, Bethesda, MD 20892, USA.
10: The University of Texas MD Anderson Cancer Center, Houston, TX 77030, USA. Electronic address: rakbani@mdanderson.org.
11: Laura and Isaac Perlmutter Cancer Center, New York University Langone Medical Center, New York, NY 10016, USA. Electronic address: douglas.levine@nyumc.org.

Articles citing this ↘

In the literature: April 2017. ESMO Open (2017) 0.75

Articles by these authors ⇆

Comprehensive genomic characterization defines human glioblastoma genes and core pathways. Nature (2008) 75.40

Integrated genomic analyses of ovarian carcinoma. Nature (2011) 47.72

Integrated genomic analysis identifies clinically relevant subtypes of glioblastoma characterized by abnormalities in PDGFRA, IDH1, EGFR, and NF1. Cancer Cell (2010) 39.09

Genomic and epigenomic landscapes of adult de novo acute myeloid leukemia. N Engl J Med (2013) 19.87

Identification of a CpG island methylator phenotype that defines a distinct subgroup of glioma. Cancer Cell (2010) 16.12

Integrated genomic characterization of endometrial carcinoma. Nature (2013) 14.29

Comprehensive molecular characterization of clear cell renal cell carcinoma. Nature (2013) 13.60

Comprehensive molecular characterization of gastric adenocarcinoma. Nature (2014) 11.93

Comprehensive molecular profiling of lung adenocarcinoma. Nature (2014) 11.02

Comprehensive molecular characterization of urothelial bladder carcinoma. Nature (2014) 8.48

Comprehensive, Integrative Genomic Analysis of Diffuse Lower-Grade Gliomas. N Engl J Med (2015) 5.71

Landscape of somatic retrotransposition in human cancers. Science (2012) 4.37

Multiplatform analysis of 12 cancer types reveals molecular classification within and across tissues of origin. Cell (2014) 4.17

Association between BRCA1 and BRCA2 mutations and survival in women with invasive epithelial ovarian cancer. JAMA (2012) 3.85

Prognostically relevant gene signatures of high-grade serous ovarian carcinoma. J Clin Invest (2012) 3.64

The Molecular Taxonomy of Primary Prostate Cancer. Cell (2015) 3.29

Comprehensive Molecular Characterization of Papillary Renal-Cell Carcinoma. N Engl J Med (2015) 3.00

Integrated genomic characterization of oesophageal carcinoma. Nature (2017) 2.76

Molecular Profiling Reveals Biologically Discrete Subsets and Pathways of Progression in Diffuse Glioma. Cell (2016) 2.27

The somatic genomic landscape of chromophobe renal cell carcinoma. Cancer Cell (2014) 2.21

Integrated analyses of microRNAs demonstrate their widespread influence on gene expression in high-grade serous ovarian carcinoma. PLoS One (2012) 1.76

Spectrum of somatic mitochondrial mutations in five cancers. Proc Natl Acad Sci U S A (2012) 1.63

Distinct patterns of somatic genome alterations in lung adenocarcinomas and squamous cell carcinomas. Nat Genet (2016) 1.16

Comprehensive Pan-Genomic Characterization of Adrenocortical Carcinoma. Cancer Cell (2016) 1.06

Integrated RNA and DNA sequencing improves mutation detection in low purity tumors. Nucleic Acids Res (2014) 1.05

Integrated genomic and molecular characterization of cervical cancer. Nature (2017) 0.96

Comprehensive and Integrative Genomic Characterization of Hepatocellular Carcinoma. Cell (2017) 0.81

Comprehensive Molecular Characterization of Pheochromocytoma and Paraganglioma. Cancer Cell (2017) 0.79

Comprehensive Pan-Genomic Characterization of Adrenocortical Carcinoma. Cancer Cell (2016) 0.76

Integrated Genomic Characterization of Pancreatic Ductal Adenocarcinoma. Cancer Cell (2017) 0.75